Residential ED denied as not FDA-approved for this use by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for residential ed are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UHC Cites "Not FDA-Approved" for Residential Eating Disorder Treatment — and Why That Reasoning Does Not Apply

UnitedHealthcare occasionally issues a "not FDA-approved" denial for residential eating disorder (ED) treatment. This language is almost always a misapplication of a drug or device approval standard to a behavioral health service. The FDA does not "approve" residential treatment programs, partial hospitalization programs, or other levels of care — those are clinical and facility services, not pharmaceutical products or medical devices. A "not FDA-approved" denial applied to a residential treatment level of care is therefore categorically inapplicable and should be challenged on that basis immediately.

If UHC is using this language to target a specific therapeutic modality or protocol used within the program (for example, a particular manualized therapy approach), the same analysis applies: psychotherapy protocols and clinical care models do not require FDA approval. They are evaluated by the clinical and scientific community and endorsed — or not — by professional organizations and peer-reviewed evidence.

## The Federal Appeal Framework

• Internal appeal: File within 180 days of denial. UHC must respond within 30 days (pre-service) or 60 days (post-service). In the appeal, explicitly challenge the applicability of the FDA-approval standard to a behavioral health residential service.
• External review (ACA §2719): After final internal denial, you have approximately 4 months to request independent external review. External reviewers apply generally accepted medical practice standards, not FDA approval status, to behavioral health services.
• MHPAEA: UHC must apply the same evidentiary and approval standards to behavioral health benefits as it applies to analogous medical/surgical residential care. It does not require that medical/surgical hospitals obtain FDA approval for their inpatient programs — the same standard must apply to behavioral health residential programs.
• ERISA §503: Employer-plan members may demand the specific policy or guideline that supports applying an FDA-approval requirement to a behavioral health service.

## Documentation to Gather

• Facility accreditation and licensure: Documentation that the residential facility is licensed by the relevant state authority and accredited by a recognized body (Joint Commission, CARF, or equivalent). These are the applicable regulatory standards for residential treatment programs — not FDA approval.
• Clinical necessity letter: A letter from the treating clinician explaining that residential eating disorder care is a standard, guideline-supported level of care and that no FDA approval framework governs its use.
• Professional organization support: Position statements from the American Psychiatric Association, Academy for Eating Disorders, or other relevant organizations confirming residential care as a recognized standard of treatment.
• UHC's denial rationale: Request the specific policy language UHC used to apply an FDA-approval criterion to this service. That document is essential to constructing the appeal.

## Criteria-Mapping Strategy

Challenge the threshold question first: state clearly in your appeal letter that the FDA does not regulate residential behavioral health treatment programs and that UHC's denial reasoning is inapplicable on its face. Then pivot to the substantive standard that does apply — generally accepted medical practice, guideline support, and clinical necessity — and provide documentation on each. Request that UHC either withdraw the denial or reissue it under the correct clinical standard, and note that applying a fabricated approval criterion to a behavioral health service while not applying an equivalent standard to medical/surgical services is a MHPAEA non-quantitative treatment limitation violation.